Stryker, one of the world’s largest medtech companies, announced on January 28 that it would be selling its Spinal Implants business to ...
Hospital has added a Stryker Mako robotic system for total knee, partial knee and total hip replacements. Robotic surgery allows for better analytics, outcomes and faster recovery for total knee, ...
The buyer, Viscogliosi Brothers, will call the company VB Spine. Stryker also reported operating results and offered its ...
Stryker's Mako shoulder robot earned FDA approval in December, Jason Beach, vice president of finance and investor relations, said in a Jan. 28 earnings call.
Once complete, the new company will have exclusive access to Stryker’s Mako Spine robotic-assisted surgical device and Copilot surgical assistance technology for use with VB Spine’s implants.
Hosted on MSN1mon
Here's Why You Should Retain Stryker Stock in Your Portfolio for NowStryker SYK is well-poised for growth, backed by a robust robotic arm-assisted surgery platform, Mako, and a diversified product portfolio. An improvement in price also buoys optimism. Shares of ...
“We believe that the spinal implants business, with its comprehensive portfolio and strong sales channel, will thrive as an independent company," said Kevin A. Lobo, Chair and Chief Executive Officer, ...
Analyst Patrick Wood from Morgan Stanley maintained a Buy rating on Stryker (SYK – Research Report) and keeping the price target at ...
Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results